Enovix Corp
Financial highlights
| Metric | FY 12/28/25 | FY 12/29/24 | FY 12/31/23 | FY 01/01/23 | FY 01/02/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $31.8M | $23.1M | $7.6M | $6.2M | $0 |
| Cost of revenue | $25.7M | $25.1M | $63.1M | $23.2M | $2.0M |
| Gross profit | $6.1M | -$2.0M | -$55.4M | -$17.0M | -$2.0M |
| Selling, general & administrative | $73.0M | $74.3M | $79.0M | $52.0M | $29.7M |
| Research and development | $110.3M | $124.5M | $88.4M | $58.1M | $37.9M |
| Operating expenses | $183.4M | $240.6M | $174.8M | $114.9M | $67.6M |
| Operating income | -$177.3M | -$242.7M | -$230.3M | -$132.0M | -$69.5M |
| Interest expense | $21.6M | $6.8M | $4.5M | $0 | $187,000 |
| Pretax income | -$157.9M | -$223.9M | -$214.8M | -$51.6M | -$125.9M |
| Income tax expense | -$1.3M | -$1.4M | -$633,000 | $0 | $0 |
| Net income | -$156.7M | -$222.2M | -$214.1M | -$51.6M | -$125.9M |
| Balance Sheet | |||||
| Cash and equivalents | $106.0M | $272.9M | $233.1M | $322.9M | $385.3M |
| Current assets | $542.2M | $295.0M | $323.2M | $329.6M | $398.1M |
| Total assets | $879.0M | $527.2M | $564.3M | $440.6M | $482.6M |
| Current liabilities | $65.0M | $53.7M | $61.0M | $23.0M | $20.6M |
| Total liabilities | $605.0M | $277.8M | $303.2M | $84.2M | $156.4M |
| Total debt | $533.0M | $174.0M | $175.8M | $0 | $0 |
| Stockholders' equity | $271.2M | $246.7M | $258.1M | $356.4M | $326.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$95.3M | -$108.6M | -$104.6M | -$82.7M | -$51.3M |
| Depreciation and amortization | $35.1M | $45.0M | $34.0M | $8.0M | $1.5M |
| Stock-based compensation | $49.4M | $58.8M | $69.5M | $30.4M | $10.7M |
| Capital expenditure | $18.2M | $76.2M | $61.8M | $36.2M | $43.6M |
| Free cash flow | -$113.5M | -$184.8M | -$166.4M | -$119.0M | -$94.9M |
| Share repurchases | $58.4M | $0 | $0 | $10,000 | $27,000 |
| Impairments | $0 | $0 | $0 | $4.9M | $0 |
Shares outstanding 218.2M · Free float 73.4%
Annual filing data through FY ended December 28, 2025; float as of July 15, 2026.